A detailed history of Lazari Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Lazari Capital Management, Inc. holds 18,895 shares of PFE stock, worth $539,830. This represents 0.24% of its overall portfolio holdings.

Number of Shares
18,895
Previous 18,359 2.92%
Holding current value
$539,830
Previous $509 Million 3.78%
% of portfolio
0.24%
Previous 0.28%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 09, 2024

BUY
$25.26 - $29.6 $13,539 - $15,865
536 Added 2.92%
18,895 $529 Million
Q1 2024

Jun 24, 2024

BUY
$25.89 - $29.73 $258 - $297
10 Added 0.05%
18,359 $509 Million
Q4 2023

Feb 27, 2024

SELL
$26.13 - $33.94 $26,130 - $33,940
-1,000 Reduced 5.17%
18,349 $528 Million
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $106,602 - $124,608
-3,322 Reduced 14.65%
19,349 $642 Million
Q2 2023

Jul 20, 2023

BUY
$36.12 - $41.79 $818,876 - $947,421
22,671 New
22,671 $832 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lazari Capital Management, Inc. Portfolio

Follow Lazari Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazari Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lazari Capital Management, Inc. with notifications on news.